Viking Global Investors Lp

13F Holdings History for BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN)

Symbol: BMRN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 8.32M shares
Security Ownership: 4.3%

Shares, Excluding Options vs Price

Value, Excluding Options

VIKING GLOBAL INVESTORS LP ownership in BIOMARIN PHARMACEUTICAL INC Common Stock, par value $0.001 per share (BMRN)

2025-11-14 - VIKING GLOBAL INVESTORS LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.32M shares of BIOMARIN PHARMACEUTICAL INC Common Stock, par value $0.001 per share (BMRN). This represents 4.3% percent ownership of the company. In their previous filing dated 2025-08-14, VIKING GLOBAL INVESTORS LP had reported owning 12.3M shares, indicating a decrease of -32.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
VIKING GLOBAL INVESTORS LP	4.3%	-35%	$451M	8.32M	-3,966,432	-32.3%	$54.16	13G/A	9/30/2025	14 Nov 2025 16:53:40
VIKING GLOBAL INVESTORS LP	6.4%		$720M	12.3M			$58.58	13G/A	6/30/2025	14 Aug 2025 17:32:47

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	1.17%	-0.56%	$451M	8.32M	-3,966,432	-32.3%	$54.16	Q3 2025
6/30/2025	1.95%	+0.24%	$676M	12.3M	+1,488,552	+13.8%	$54.97	Q2 2025
3/31/2025	2.43%	+0.07%	$763M	10.8M	+289,509		$70.69	Q1 2025
12/31/2024	2.24%	+0.16%	$691M	10.5M	+757,257	+7.76%	$65.73	Q4 2024
9/30/2024	2.5%	+0.69%	$686M	9.75M	+2,689,729	+38.1%	$70.29	Q3 2024
6/30/2024	2.24%	+0.2%	$582M	7.06M	+647,276	+10.1%	$82.33	Q2 2024
3/31/2024	2.09%	+0.49%	$560M	6.42M	+1,526,834	+31.2%	$87.34	Q1 2024
12/31/2023	1.73%	+0.26%	$471M	4.89M	+673,998	+16%	$96.42	Q4 2023
9/30/2023	1.51%	+0.02%	$373M	4.22M	+58,671	+1.41%	$88.48	Q3 2023
6/30/2023	1.48%	+0.71%	$360M	4.16M	+1,988,168	+91.7%	$86.68	Q2 2023
3/31/2023	0.99%	-1.42%	$211M	2.17M	-3,105,003	-58.9%	$97.24	Q1 2023
12/31/2022	2.73%	+0.09%	$546M	5.27M	+174,456	+3.42%	$103.49	Q4 2022
9/30/2022	2%	+0.02%	$432M	5.1M	+46,571	+0.92%	$84.77	Q3 2022
6/30/2022	1.92%	+0.49%	$419M	5.05M	+1,300,200	+34.6%	$82.87	Q2 2022
3/31/2022	1.17%	+0.28%	$289M	3.75M	+882,446	+30.7%	$77.10	Q1 2022
12/31/2021	0.73%	+0.73%	$254M	2.87M	+2,869,947	NEW	$88.35	Q4 2021
6/30/2020		-0.64%	$0	0	-1,453,625	-100%		Q2 2020
3/31/2020	0.64%	-0.07%	$123M	1.45M	-168,114	-10.4%	$84.50	Q1 2020
12/31/2019	0.64%	-0.57%	$137M	1.62M	-1,436,365	-47%	$84.55	Q4 2019
9/30/2019	1.07%	+0.16%	$206M	3.06M	+467,753	+18.1%	$67.40	Q3 2019
6/30/2019	1%	-0.98%	$222M	2.59M	-2,538,558	-49.5%	$85.65	Q2 2019
3/31/2019	2.61%	+0.02%	$456M	5.13M	+37,272	+0.73%	$88.83	Q1 2019
12/31/2018	2.47%	+0.47%	$434M	5.09M	+962,696	+23.3%	$85.15	Q4 2018
9/30/2018	2.22%	+0.47%	$400M	4.13M	+869,184	+26.7%	$96.97	Q3 2018
6/30/2018	1.76%	+0.85%	$307M	3.26M	+1,577,291	+93.7%	$94.20	Q2 2018
3/31/2018	0.82%	+0.82%	$136M	1.68M	+1,682,466	NEW	$81.07	Q1 2018
9/30/2017		-0.16%	$0	0	-259,656	-100%		Q3 2017
6/30/2017	0.16%	-0.38%	$23.6M	260K	-616,457	-70.4%	$90.82	Q2 2017
3/31/2017	0.34%	-0.2%	$76.9M	876K	-522,344	-37.4%	$87.78	Q1 2017
12/31/2016	0.53%	+0.34%	$116M	1.4M	+908,153	+185%	$82.84	Q4 2016
9/30/2016	0.2%	+0.2%	$45.4M	490K	+490,304	NEW	$92.52	Q3 2016
6/30/2016		-0.22%	$0	0	-602,116	-100%		Q2 2016
3/31/2016	0.22%	+0.22%	$49.7M	602K	+602,116	NEW	$82.48	Q1 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.